🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
SGM
$SGMOQ
🔒 US EquitiesSangamo Therapeutics Inc
AVG HISTORICAL GAP
-9.14%
MAX GAP RECORD
-37.33%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $SGMOQ
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$SGMOQ
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 28, 2026 Earnings Release 2026-10-28 (UNDETERMINED) |
+0.00%
|
| Aug 11, 2026 Earnings Release 2026-08-11 (AFTER CLOSE) |
+0.00%
|
| Mar 30, 2026 Earnings Release 2026-03-30 (AFTER CLOSE) |
-22.58%
|
| Nov 06, 2025 Earnings Release 2025-11-06 (BEFORE OPEN) |
-23.64%
|
| Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE) |
-6.25%
|
| May 12, 2025 Earnings Release 2025-05-12 (AFTER CLOSE) |
-37.33%
|
| Mar 17, 2025 Earnings Release 2025-03-17 (AFTER CLOSE) |
-9.90%
|
| Nov 12, 2024 Earnings Release 2024-11-12 (AFTER CLOSE) |
-16.97%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
12.6%
Bullish Gaps (4)
Bearish Gaps (7)
Neutral / Flat (0)
📖 Intelligence Summary
Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. The firm focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which consist of inflammatory and autoimmune diseases. It also offers complementary technology platforms…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗